Sino Biopharmaceutical | 1177 - Cost Of Sales

Stock Price
5.42
Daily Change
-0.04 -0.73%
Monthly
-7.98%
Yearly
36.52%
Q2 Forecast
5.50

Sino Biopharmaceutical reported CNY3.08B in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.24B 518M Dec/2025
Jiangsu Hengrui CNY 1.09B 76.27M Mar/2026
Moderna USD 452M 245M Dec/2025
Organon & Co USD 745M 25M Sep/2025
Revvity USD 350.4M 26.05M Dec/2025
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Viatris USD 2.56B 167.3M Dec/2025
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025